CA2257296A1 - Composes antiviraux - Google Patents
Composes antiviraux Download PDFInfo
- Publication number
- CA2257296A1 CA2257296A1 CA002257296A CA2257296A CA2257296A1 CA 2257296 A1 CA2257296 A1 CA 2257296A1 CA 002257296 A CA002257296 A CA 002257296A CA 2257296 A CA2257296 A CA 2257296A CA 2257296 A1 CA2257296 A1 CA 2257296A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- compound
- pharmaceutically acceptable
- halo
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
L'invention porte sur une série de composés de benzimidazole inhibant la croissance des picornavirus tels que le rhinovirus, l'entérovirus, le poliovirus, le virus Coxsackie des groupes A et B, l'échovirus, le virus de Mengo, et les flavivirus tels que le virus de l'hépatite C et le virus de la diarrhée bovine.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1917096P | 1996-06-05 | 1996-06-05 | |
US60/019,170 | 1996-06-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2257296A1 true CA2257296A1 (fr) | 1997-12-11 |
Family
ID=21791797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002257296A Abandoned CA2257296A1 (fr) | 1996-06-05 | 1997-06-05 | Composes antiviraux |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0906097A4 (fr) |
JP (1) | JP2000511899A (fr) |
KR (1) | KR20000016346A (fr) |
CN (1) | CN1220601A (fr) |
AU (1) | AU3212897A (fr) |
BR (1) | BR9709528A (fr) |
CA (1) | CA2257296A1 (fr) |
EA (1) | EA001316B1 (fr) |
WO (1) | WO1997046237A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5821242A (en) * | 1996-06-06 | 1998-10-13 | Eli Lilly And Company | Anti-viral compounds |
AU6031898A (en) * | 1997-01-22 | 1998-08-07 | Eli Lilly And Company | Anti-viral compounds |
CA2293508A1 (fr) * | 1997-06-04 | 1998-12-10 | Louis Nickolaus Jungheim | Composes antiviraux |
WO1999059587A1 (fr) * | 1998-05-20 | 1999-11-25 | Eli Lilly And Company | Composes anti-viraux |
US6770666B2 (en) | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
TR200103147T1 (tr) * | 1999-12-27 | 2002-06-21 | Japan Tobacco Inc. | Kaynaşık halkalı bileşikler ve bunların ilaç olarak kullanımı. |
EP1651631A1 (fr) | 2003-08-01 | 2006-05-03 | Genelabs Technologies, Inc. | Derives de l'imidazole bicycliques diriges contre les flaviviridae |
JP4143669B2 (ja) | 2004-02-24 | 2008-09-03 | 日本たばこ産業株式会社 | 4環縮合複素環化合物及びそのhcvポリメラーゼ阻害剤としての利用 |
US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4434288A (en) * | 1982-04-08 | 1984-02-28 | Eli Lilly And Company | Preparation of substituted 1-thiazinyl or 1-thiazolyl-2-aminobenzimidazoles |
US4420479A (en) * | 1982-04-08 | 1983-12-13 | Eli Lilly And Company | Olefinic benzimidazoles, formulations, and antiviral methods |
US4492708A (en) * | 1982-09-27 | 1985-01-08 | Eli Lilly And Company | Antiviral benzimidazoles |
-
1997
- 1997-06-05 CN CN97195098A patent/CN1220601A/zh active Pending
- 1997-06-05 CA CA002257296A patent/CA2257296A1/fr not_active Abandoned
- 1997-06-05 AU AU32128/97A patent/AU3212897A/en not_active Abandoned
- 1997-06-05 WO PCT/US1997/008848 patent/WO1997046237A1/fr not_active Application Discontinuation
- 1997-06-05 JP JP10500630A patent/JP2000511899A/ja active Pending
- 1997-06-05 BR BR9709528A patent/BR9709528A/pt not_active Application Discontinuation
- 1997-06-05 KR KR1019980709919A patent/KR20000016346A/ko not_active Application Discontinuation
- 1997-06-05 EA EA199801078A patent/EA001316B1/ru not_active IP Right Cessation
- 1997-06-05 EP EP97927738A patent/EP0906097A4/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EA001316B1 (ru) | 2001-02-26 |
EA199801078A1 (ru) | 1999-04-29 |
BR9709528A (pt) | 1999-08-10 |
AU3212897A (en) | 1998-01-05 |
KR20000016346A (ko) | 2000-03-25 |
WO1997046237A1 (fr) | 1997-12-11 |
JP2000511899A (ja) | 2000-09-12 |
EP0906097A4 (fr) | 2000-12-13 |
CN1220601A (zh) | 1999-06-23 |
EP0906097A1 (fr) | 1999-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5891874A (en) | Anti-viral compound | |
US5821242A (en) | Anti-viral compounds | |
US5545653A (en) | Anti-viral compounds | |
JPS591712B2 (ja) | 1−(2−チエニルスルホニル)ベンゾイミダゾ−ル化合物 | |
CA2257296A1 (fr) | Composes antiviraux | |
US6114327A (en) | Anti-viral compounds | |
US4140785A (en) | N-(benzothienopyrazol)amide antirhinoviral agents | |
US6087374A (en) | Anti-viral compounds | |
US4118573A (en) | Substituted 1-sulfonylbenzimidazoles | |
EP0209106B1 (fr) | Dérivés du (pyridyl-4 aminométhyl)-2 benzimidazole et compositions pharmaceutiques | |
US6358971B1 (en) | Anti-viral compounds | |
US5693661A (en) | Anti-viral compounds | |
US4316021A (en) | Substituted 1-sulfonylbenzimidazoles | |
MXPA98010207A (en) | Antivira compounds | |
MXPA97009660A (en) | Antivira compounds | |
CS202556B2 (cs) | Způsob výroby 1-sulfonylbenzimidazolů, substituovaných na karbonylové skupině | |
PL110143B1 (en) | Method of producing new carbonyl substituted 1-sulfonylobenzimidazoles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |